The At5g17730 Antibody (Product Code: CSB-PA290523XA01DOA) is a polyclonal antibody designed to detect the protein product of the At5g17730 gene in Arabidopsis thaliana. This gene locus encodes a protein with the UniProt identifier Q9FN78, though its exact biochemical function remains uncharacterized . The antibody’s specificity arises from its paratope structure, which binds to epitopes unique to the At5g17730 protein .
The At5g17730 Antibody is utilized in multiple experimental workflows:
While specific validation data for this antibody are not publicly disclosed, industry standards suggest:
Specificity: Verified via knockout/knockdown Arabidopsis lines to confirm absence of cross-reactivity .
Batch Consistency: Ensured through mass spectrometry (MS) and size-exclusion chromatography (SEC) .
Though direct studies using this antibody are not cited in available literature, analogous research on Arabidopsis antibodies reveals:
Role in Stress Pathways: Antibodies against uncharacterized proteins often uncover roles in abiotic stress (e.g., drought, salinity) through expression profiling .
Developmental Regulation: Proteins detected by such antibodies may influence root or shoot development, as seen in related studies .
AT5G17730 encodes a P-loop containing nucleoside triphosphate hydrolases superfamily protein in Arabidopsis thaliana with significant enrichment (8.0 fold) in WRKY33 transcription factor binding studies . This protein belongs to a family involved in ATP binding and hydrolysis, playing potential roles in stress responses. Understanding its function through antibody-based detection helps elucidate plant stress response pathways, particularly in submergence conditions where it has been identified as a WRKY33 target gene.
For AT5G17730 protein detection, both polyclonal and monoclonal antibodies have specific applications. Polyclonal antibodies offer broad epitope recognition but with potential cross-reactivity issues. Monoclonal antibodies provide higher specificity for distinct epitopes. For studying protein complexes involving AT5G17730, specialized approaches similar to those used for protein complexes like BTLA-HVEM may be necessary, where fusion proteins are created to maintain complex stability during antibody generation .
Validation should follow a multi-step approach:
ELISA testing against purified AT5G17730 protein
Western blot analysis with plant tissue extracts (wild-type vs knockout lines)
Immunoprecipitation followed by mass spectrometry
Immunofluorescence comparing signal between control and knockout plants
Similar to methods used in other antibody studies, specificity can be determined through comparative binding assays that measure antibody binding to target versus non-target proteins .
| Sample Type | Preparation Method | Buffer Composition | Considerations |
|---|---|---|---|
| Whole plant tissue | Flash freezing, grinding in liquid N₂ | 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, protease inhibitors | Include phosphatase inhibitors for phosphorylation studies |
| Cell suspension | Gentle lysis with non-ionic detergent | PBS with 0.1% NP-40 | Maintain temperature at 4°C throughout |
| Nuclear extracts | Nuclear isolation followed by salt extraction | 20mM HEPES pH 7.9, 420mM NaCl, 1.5mM MgCl₂, 0.2mM EDTA, 25% glycerol | Critical for transcription factor interaction studies |
| Membrane fractions | Differential centrifugation | 10mM Tris-HCl pH 7.4, 250mM sucrose, 1mM EDTA | Useful for localization studies |
Based on existing WRKY33 ChIP-seq protocols, optimizing ChIP-seq for AT5G17730 requires:
Crosslinking modification: Use 1% formaldehyde for 10 minutes at room temperature for efficient crosslinking of protein-DNA complexes
Chromatin fragmentation: Sonicate to achieve fragments of 100-400 bp as used in successful WRKY33 ChIP-seq experiments
Antibody selection: Use highly specific anti-AT5G17730 antibodies, potentially with epitope tags if working with transgenic plants
Enrichment analysis: Apply MACS2 program with a false discovery cutoff of 0.05, similar to methods that successfully identified AT5G17730 as a WRKY33 target
Peak validation: Verify binding sites using techniques like ChIP-qPCR focused on the promoter regions containing the "TC box" (TCTCTC) motif identified in WRKY33 binding studies
To investigate AT5G17730 protein complexes:
Co-immunoprecipitation with stabilizing crosslinkers is recommended to preserve transient interactions triggered by stress.
Consider a fusion protein approach similar to that developed for the BTLA-HVEM complex, which successfully maintained complex integrity during antibody production .
Blue native PAGE can separate intact protein complexes while maintaining their native state.
Proximity-based labeling methods like BioID can identify transient interaction partners.
For in vivo validation, bimolecular fluorescence complementation (BiFC) provides visualization of protein interactions in plant cells.
The choice of method should account for the potentially transient nature of stress-induced interactions, as observed in other stress-responsive protein complexes.
Developing highly specific monoclonal antibodies for AT5G17730 requires a strategic approach:
Epitope selection: Identify unique, surface-exposed regions of AT5G17730 using structural prediction tools, focusing on domains that are distinct from other P-loop containing proteins
Immunization strategy: Use either synthetic peptides or recombinant protein fragments as immunogens
Hybridoma screening: Implement a multi-tier screening approach combining ELISA, western blot, and functional assays
Clonotype analysis: Sequence antibody variable regions to identify distinct clonotypes, as performed in IL17A antibody isolation studies
Neutralization assessment: If developing antibodies to block protein function, establish cell-based assays to evaluate functional neutralization
Research on mining autoantibody repertoires demonstrates that multiple rounds of selection can yield antibodies with diverse binding properties and functional characteristics .
For studying post-translational modifications (PTMs) of AT5G17730:
Cross-reactivity can be systematically addressed through:
Absorption controls: Pre-absorb antibody with recombinant AT5G17730 protein to confirm specificity
Knockout validation: Compare antibody reactivity in wild-type versus AT5G17730 knockout plants
Epitope mapping: Identify precisely which regions of the protein are recognized by the antibody
Western blot optimization: Adjust blocking conditions (5% milk versus 3% BSA) and increase wash stringency
Immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody
These approaches are conceptually similar to those used in other antibody specificity studies, such as those performed with IgLON5 antibodies where glycosylation factors were systematically evaluated .
| Problem | Possible Causes | Solutions | Validation Method |
|---|---|---|---|
| Signal variability between replicates | Inconsistent stress application | Standardize stress treatment protocols; use controlled environment chambers | Include internal controls for stress markers |
| Signal loss after certain treatments | Protein degradation during extraction | Add additional protease inhibitors; maintain cold chain; optimize extraction buffer | Spike in known quantity of recombinant protein |
| Background signal in control samples | Antibody cross-reactivity | Increase antibody dilution; optimize washing steps; use alternative blocking agents | Include peptide competition assay |
| Differential signal between tissue types | Variable expression or accessibility | Optimize extraction methods for each tissue type; consider native versus denaturing conditions | Compare with transcript levels via RT-qPCR |
| Loss of signal in time-course experiments | Protein turnover or epitope masking | Sample at more frequent intervals; use multiple antibodies targeting different epitopes | Monitor protein levels with alternative methods |
Discrepancies between protein and mRNA levels require systematic investigation:
Temporal dynamics: Implement time-course experiments with staggered sampling to account for delays between transcription and translation
Post-transcriptional regulation: Assess mRNA stability and translation efficiency through polysome profiling
Post-translational regulation: Investigate protein stability through cycloheximide chase experiments
Protein localization changes: Use subcellular fractionation to determine if changes in localization affect detection
Epitope masking: Test alternative antibodies targeting different regions of AT5G17730
This analytical approach resembles methods used to investigate discrepancies in WRKY33 regulated genes, where transcript levels and protein function showed distinct patterns during stress responses .
AT5G17730 antibodies can be integrated into submergence stress studies by:
Chromatin immunoprecipitation studies to determine if AT5G17730 directly interacts with submergence-responsive promoters containing the "TC box" (TCTCTC) motif identified in WRKY33 studies
Co-immunoprecipitation followed by mass spectrometry to identify interaction partners that change during submergence
Immunolocalization to track changes in subcellular distribution during stress
Quantitative western blot analysis to measure protein abundance changes in comparison to transcript level changes
Phosphorylation-specific antibody development to monitor stress-induced post-translational modifications
These approaches leverage the finding that AT5G17730 is a target of WRKY33 transcription factor binding during submergence stress, with an enrichment fold of 8.0 in ChIP-seq studies .
To investigate AT5G17730 complex formation during oxidative stress:
Sequential co-immunoprecipitation: First pull down with AT5G17730 antibody, then with antibodies against suspected complex partners
Native gel electrophoresis with western blotting to preserve and detect intact complexes
Size-exclusion chromatography coupled with antibody detection to separate complexes by size
In situ proximity ligation assay to visualize protein interactions within plant cells
FRET/FLIM microscopy with fluorescently tagged proteins to detect direct interactions in vivo
This experimental approach is informed by studies of stress-responsive proteins involved in oxidation-reduction processes, which were identified as significant functional categories for WRKY33 target genes .
Given that WRKY33 is a key regulator of plant immunity and AT5G17730 is a target gene, antibodies can be applied to understand immunity pathways through:
Monitoring protein abundance changes during pathogen infection compared to PAMP treatments
Investigating co-localization with known immune signaling components like NADPH oxidases
Analyzing protein modifications (phosphorylation, ubiquitination) during immune responses
Comparative studies between wild-type and defense-compromised mutants
Determining if AT5G17730 associates with nucleotide-binding leucine-rich repeat (NLR) receptor complexes
When designing these experiments, consider the approaches used in anti-cytokine autoantibody studies, where antibody neutralization assays provided insights into functional significance .
Integrating AT5G17730 antibodies with single-cell techniques:
Single-cell immunostaining with AT5G17730 antibodies combined with tissue clearing techniques can reveal cell-type specific expression patterns
Combining laser capture microdissection with immunoblotting allows for cell-type specific protein quantification
Proximity labeling (TurboID or APEX2 fused to AT5G17730) with cell-type specific promoters can identify interaction networks in specific cell populations
Spatial transcriptomics paired with in situ protein detection can correlate transcript and protein levels with high spatial resolution
Mass cytometry (CyTOF) with metal-conjugated antibodies enables multiplexed protein detection at single-cell resolution
These approaches extend beyond traditional immunolocalization to provide quantitative, spatially resolved data on AT5G17730 dynamics during stress responses.
Novel antibody technologies that could advance AT5G17730 research include:
| Technology | Application | Advantage | Implementation Consideration |
|---|---|---|---|
| Nanobodies (VHH antibodies) | Intracellular immunoprecipitation | Small size allows better tissue penetration and intracellular expression | Requires specialized immunization of camelids or synthetic libraries |
| Bi-specific antibodies | Simultaneous detection of AT5G17730 and interaction partners | Enables co-detection without secondary antibody complications | Complex production but can be achieved with recombinant techniques |
| SOMAmers (DNA aptamers) | Non-antibody based detection | Stable under harsh conditions; highly specific | Requires extensive selection and validation process |
| Antibody fragments (Fab, scFv) | Improved tissue penetration | Reduced non-specific binding due to Fc removal | May have reduced affinity compared to full antibodies |
| Recombinant renewable antibodies | Consistent supply of identical antibody | Eliminates batch-to-batch variation | Requires initial hybridoma sequencing or phage display selection |
Adapting techniques from human monoclonal antibody isolation, as demonstrated in the isolation of IL17A-specific antibodies , could be particularly valuable.